Zymeworks (ZYME) Total Liabilities (2021 - 2026)
Zymeworks (ZYME) reported Total Liabilities of $314.6 million for Q1 2026, up 212.89% on a YoY basis from $100.6 million in Q1 2025, and up 303.23% sequentially from $78.0 million in Q4 2025.
Zymeworks (ZYME) Total Liabilities (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Total Liabilities data on file, last reported at $314.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 212.89% year-over-year to $314.6 million; the trailing twelve-month figure through Mar 2026 stood at $314.6 million (up 212.89% YoY), and the FY2025 full-year result was $78.0 million, down 37.24% from the prior year.
- Total Liabilities rose to $314.6 million in Q1 2026, from $78.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $314.6 million in Q1 2026 to a low of $73.9 million in Q2 2025.
- A 5-year average of $127.9 million and a median of $120.2 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities sank 37.24% in 2025 and jumped 212.89% in 2026, its largest moves.
- Tracing ZYME's Total Liabilities over 5 years: stood at $155.8 million in 2022, then declined by 25.48% to $116.1 million in 2023, then climbed by 7.11% to $124.3 million in 2024, then slumped by 37.24% to $78.0 million in 2025, then jumped by 303.23% to $314.6 million in 2026.
- Business Quant data shows ZYME's Total Liabilities at $314.6 million in Q1 2026, $78.0 million in Q4 2025, and $77.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - | 314.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 314.63 Mn |
| Dec 31, 2025 | 78.03 Mn |
| Sep 30, 2025 | 77.21 Mn |
| Jun 30, 2025 | 73.88 Mn |
| Mar 31, 2025 | 100.56 Mn |
| Dec 31, 2024 | 124.32 Mn |
| Sep 30, 2024 | 120.17 Mn |
| Jun 30, 2024 | 109.47 Mn |
| Mar 31, 2024 | 115.75 Mn |
| Dec 31, 2023 | 116.07 Mn |
| Sep 30, 2023 | 132.02 Mn |
| Jun 30, 2023 | 153.14 Mn |
| Mar 31, 2023 | 127.21 Mn |
| Dec 31, 2022 | 155.77 Mn |
| Sep 30, 2022 | 120.51 Mn |
| Dec 31, 2021 | 140.04 Mn |